您的位置: 首页 > 农业专利 > 详情页

4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as Btk- inhibitors
专利权人:
Merck Sharp & Dohme B.V.
发明人:
BARF, Tjeerd A.,JANS, Christiaan Gerardus Johannes Maria,MAN, De Adrianus Petrus Antonius,OUBRIE, Arthur A.,RAAIJMAKERS, Hans C. A.,REWINKEL, Johannes Bernardus Maria,STERRENBURG, Jan-Gerard,WIJKMANS,
申请号:
AU2017279778
公开号:
AU2017279778B2
申请日:
2017.12.22
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
4 - IMIDAZOPYRIDAZIN- 1 -YL-BENZAMIDES AND 4 IMIDAZOTRIAZIN- 1 - YL - BENZAMIDES AS BTK- INHIBITORS The present invention relates to 6-5 membered fused pyridine ring compounds according to formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充